Skip to content

WEBINAR: Cell-Free Protein Screening to Predict Scale-Up Success - Watch

Sprite
  • Products & Services
  • Applications
    • Drug Discovery
    • AlphaFold Protein Design
    • Membrane Protein
  • Technology
  • Resources
    • Resources Library
    • Webinars
    • Events
    • Case Studies
    • Blogs
  • Company
    • About Us
    • Team
    • Careers
    • Investors
    • News
    • Corporate Social Responsibility
  • Contact Us
Menu
Sprite
  • Products & Services
    • System
  • Applications
    • Drug Discovery
    • AlphaFold Protein Design
    • Membrane Protein
  • Technology
  • Resources
    • Resources Library
    • Webinars
    • Events
    • Case Studies
    • Blogs
  • Company
    • About Us
    • Team
    • Careers
    • Investors
    • News
    • Corporate Social Responsibility
  • Contact Us
Row SystemWave Shape Decorative svg added to bottom

Nuclera News

Read our latest press releases and news developments

    ">

    FEATURED NEWS

    Nuclera launches antibody triage service to advance AI-driven antibody discovery

Filter by

Group 616

News Type

  • Blog
  • Company Announcements
  • General News
  • Investor News

Year

  • 2021
  • 2022
  • 2023
  • 2024
  • 2025
  • 2026
Open Filter

      Blog

      Built for AI Antibody Design. Accelerating the DBTL Cycle.

      July 10, 2026

      Blog

      Overcoming the AI Antibody Validation Bottleneck with Early Hit Triage

      June 4, 2026

      Company Announcements

      Nuclera launches antibody triage service to advance AI-driven antibody discovery

      May 11, 2026

      Company Announcements General News

      Nuclera launches GPCR-focused nanodisc panel to streamline membrane protein production

      March 30, 2026

      Blog

      Webinar recap: Frank Bernhard’s Cell-Free Workflow for Cryo-EM–Ready Membrane Protein Complexes

      March 20, 2026

      Blog

      A Faster Route to Active G-protein coupled receptors (GPCRs)

      March 6, 2026

      General News

      Nuclera and leadXpro partner to accelerate structure-based drug design for complex membrane proteins

      February 17, 2026

      leadXpro scientists with the eProtein Discovery System

      Blog

      Nanodiscs explained: a practical guide for membrane protein scientists

      February 16, 2026

      Company Announcements Investor News

      Nuclera extends Series C funding to $87M to advance antibody engineering

      January 13, 2026

      Nuclera extends Series C funding to $87M to advance antibody engineering with photo of Dr Michael Chen, CEO and co-founder, Nuclera in a lab coat.

      General News

      Nuclera eProtein Discovery System installed at leading Universities in Taiwan

      January 7, 2026

    Row FooterWave Shape Decorative svg added to top
    footer-logo
    Contact Us

    System

    • Instrument
    • Cartridge
    • Reagents
    • Software

    Services

    • Antibody
    Contact Us

    Resources

    Resources
    • Resources Library
    • Webinars & Events
    • Case Studies
    • Blogs

    Applications

    Applications
    • Drug Discovery
    • AlphaFold Protein Design
    • Membrane Protein

    Our Technology

    Our Technology
    • Technology

    COMPANY

    COMPANY
    • About Us
    • Team
    • Careers
    • Investors
    • News
    • Distributors

    Follow Us

    Sprite

    Sign up to get the latest technology and resource updates

    Follow Us

    Sprite

    © 2026 Nuclera. All rights reserved.

    Privacy Policy  |  Legal

    eProtein Discovery System

    Automated multiplex protein screening system.
    Explore by Protein Type:
    Membrane

    Cartridge-menu

    Cartridge

    Reagents-menu

    Reagents

    systemimg-menu

    Software

    Instrument-menu

    Instrument

    Expression and Purification Services

    Access eProtein Discovery technology as a service.

    Antibody Services Icon

    Antibody Services